WHO ICTRP trial
Phase I/II clinical trial of WT1 peptide vaccine for the children with…
JPRN-UMIN000002990 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000002990 |
|---|---|
| Public title | Phase I/II clinical trial of WT1 peptide vaccine for the children with malignancies |
| Scientific title | Phase I/II clinical trial of WT1 peptide vaccine for the children with malignancies - WT1 peptide vaccination to the children with malignancies |
| Primary sponsor | Osaka Medical Center and Research Institute for Maternal and Child Health |
| Secondary sponsors | Tokyo Medical and Dental University, etc. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | pediatric acute leukemia or pediatric malignant solid tumors |
| Interventions | WT1 peptide + montanide adjuvant. every week x 12 times (= 3 months). |
| Registration date | Dec 1, 2010 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: